Supply of medicines containing anifrolumab 2026

Summary

The tender is for the supply, over 12 months, of medicines containing the active ingredient anifrolumab for biological treatment to the rheumatology institute in Piešťany. Bids must be submitted electronically. The successful bidder will be selected on the basis of the lowest total price including VAT, and an electronic auction will also be used. The bid guarantee is EUR 3,100 for each lot, and bids must remain valid until 31 July 2027. Precise qualification and compliance requirements must be checked in the tender documents. If a group of bidders is awarded the contract, it must establish a suitable legal form or other legal relationship for contract performance before signing.